Back to homepage

Tag "atopic dermatitis"

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib

Authors: Novin Nezamololama, BSc, MSc, Keira Fieldhouse, BSc, Kristy Metzger, BSc, Melinda Gooderham, MD, MSc, FRCPC

This review summarizes the clinical data available from various trials and reports on the safety and efficacy of abrocitinib, baricitinib, and upadacitinib, the three oral systemic JAK inhibitors used in the treatment of atopic dermatitis.

More

Conjunctivitis in patients with atopic dermatitis treated with dupilumab

Authors: Sandra Ferreira MD, Tiago Torres MD, PhD

The present paper reviews the data of dupilumab-associated conjunctivitis and risk factors in adults with moderate-to-severe AD and other atopic diseases in dupilumab clinical trials and addresses the characteristics and treatment options available for this clinically highly relevant condition.

More

Dismissing the fallacies of childhood eczema management: case scenarios and an overview of best practices

Authors: Kam Lun Hon MBBS, MD (CUHK), FAAP, FCCM, Kin Fon Leong MBBS, MRCPCH, Theresa Leung MBBS, FRCPCH, FHKAM(Paed), FHKCPaed, Alexander KC Leung MBBS, FRCPC, FRCP(UK & Irel), FRCPCH, FAAP

AD is often complicated and difficult to manage in many Asian cities and effective therapy is impeded by fallacies. In this article eleven anonymized case scenarios are described to illustrate issues associated with these fallacies. A literature review is performed and possible solutions to handle or dismiss these fallacies are discussed.

More

Emollient treatment of atopic dermatitis: latest evidence and clinical considerations

Authors: Kam Lun Hon MBBS, MD, FAAP, FCCM, Jeng Sum Charmaine Kung BSc, Wing Gi Gigi Ng BSc, Ting Fan Leung MBChB, MD, MRCP, FRCPCH

This article reviews current classes of emollients in the market, their clinical evidence in atopic dermatitis and considerations for choice of an emollient.

More

Atopic dermatitis: a review of topical nonsteroid therapy

Authors: Ariana Papier BA, Lindsay C Strowd MD

This review focuses on the safety and efficacy of topical calcineurin and PDE4 inhibitors for the treatment of atopic dermatitis.

More